These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1984664)

  • 1. The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes.
    Haffar OK; Dowbenko DJ; Berman PW
    Virology; 1991 Jan; 180(1):439-41. PubMed ID: 1984664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
    Katz E; Wolffe EJ; Moss B
    J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    Gabuzda D; Olshevsky U; Bertani P; Haseltine WA; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.
    Haffar OK; Nakamura GR; Berman PW
    J Virol; 1990 Jun; 64(6):3100-3. PubMed ID: 2186180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes.
    Haffar OK; Dowbenko DJ; Berman PW
    J Cell Biol; 1988 Nov; 107(5):1677-87. PubMed ID: 3053734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):473-9. PubMed ID: 8661397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
    Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
    Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
    Johnson JE; Rodgers W; Rose JK
    Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain.
    Wilk T; Pfeiffer T; Bukovsky A; Moldenhauer G; Bosch V
    Virology; 1996 Apr; 218(1):269-74. PubMed ID: 8615034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy.
    Lin X; Dashti A; Schinazi RF; Tang J
    FASEB J; 1993 Aug; 7(11):1070-80. PubMed ID: 8370478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.
    Moulard M; Montagnier L; Bahraoui E
    FEBS Lett; 1994 Feb; 338(3):281-4. PubMed ID: 8307195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
    Polydefkis M; Koenig S; Flexner C; Obah E; Gebo K; Chakrabarti S; Earl PL; Moss B; Siliciano RF
    J Exp Med; 1990 Mar; 171(3):875-87. PubMed ID: 1968506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    Bültmann A; Muranyi W; Seed B; Haas J
    J Virol; 2001 Jun; 75(11):5263-76. PubMed ID: 11333908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing and routage of HIV glycoproteins by furin to the cell surface.
    Moulard M; Hallenberger S; Garten W; Klenk HD
    Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
    Wells DE; Compans RW
    Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HIV-1 envelope glycoprotein alters cellular calmodulin.
    Radding W; Pan ZQ; Hunter E; Johnston P; Williams JP; McDonald JM
    Biochem Biophys Res Commun; 1996 Jan; 218(1):192-7. PubMed ID: 8573130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.